The 58 references in paper S. Arutyunyan S., N. Savenkova D., V. Larionova I., С. Арутюнян С., Н. Савенкова Д., В. Ларионова И. (2010) “АУТОСОМНО-ДОМИНАНТНЫЙ ПОЛИКИСТОЗ ПОЧЕК У ВЗРОСЛЫХ И ДЕТЕЙ // AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE IN CHILDREN AND ADULTS” / spz:neicon:nefr:y:2010:i:3:p:58-68

1
Bergmann C, Zerres K. Polycystic Kidney Disease: ADPKD and ARPKD. In:Comprehensive Pediatric Nephrology. Geary DF, Schaefer-Mosby F. eds. Elsevier, 2008;155-178
(check this in PDF content)
2
Dell K,Sweeney WE. Polycystic Kidney Disease. In:Pediatric Nephrology-Sixth edition Avner E.D., Harmon WE, Niaudet P, Yoshikawa N. eds. Springer, 2009; 849-887
(check this in PDF content)
3
Somlo S, Guay-Woodford LM. Polycystic Kidney Disease. In: Genetic Diseases o f the Kidney. Lifton R, Somlo S, Giebisch G, Donald W.et al: Elsevier 2009; 393-424
(check this in PDF content)
4
Wilson PD. Polycystic kidney disease. N Engl J Med 2004; 350:151-164
(check this in PDF content)
5
Paterson A, Pei Y. A third gene for autosomal dominant polycystic kidney disease? Kidney Int 1998; 54: 1759-1761
(check this in PDF content)
6
Paterson AD, Wang KR, Lupea D, St George-Hyslop P et al. Recurrent fetal loss associated with bilineal inheritance of type 1 autosomal dominant polycystic kidney disease. Am J Kidney Dis 2002; 40(1):16-20
(check this in PDF content)
7
Martin J, Han C, Gordon LA et al. The sequence and analysis of duplication-rich human chromosome 16. Nature 2004; 432: 988-994
(check this in PDF content)
8
Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev 2007; 87: 165-217
(check this in PDF content)
9
Huang AL, Chen X, Hoon MA et al. The cells and logic for mammalian sour detection. Nature 2006; 442: 934-938
(check this in PDF content)
10
Driscoll JA, Bhalla S, Liapis H, Ibricevic A et al. Autosomal dominant polycystic kidney disease is associated with an increased prevalence of radiographic bronchiectasis. Chest 2008;133(5):1181-1198
(check this in PDF content)
11
Scheffers MS, van der BP, Prins F et al. Polycystin-1, the prod-uct of the polycystic kidney disease 1 gene, co­ localizes with desmosomes in MDCK cells. Hum Mol Genet 2000; 9: 2743-2750
(check this in PDF content)
12
Li A, Tian X, Sung SW, Somlo S. Identification of two novel polycystic kidney disease 1-like genes in human and mouse genomes. Genomics 2003; 82: 498-500
(check this in PDF content)
13
Hidaka S, Konecke V, Osten L et al. PIGEA-14, a novel coiled-coil protein affecting the intracellular distribution of polycystin-2. J Biol Chem 2004; 279:35009-35016
(check this in PDF content)
14
Reeders ST Multilocus polycystic disease. Nat Genet 1992;1:235-237
(check this in PDF content)
15
Jiang ST, Chiou YY et al. Defining a link with ADPKD in mice with con-genitally low expression of Pkdl. Am J Pathol 2006;8: 205-220
(check this in PDF content)
16
Thivierge C, Kurbegovic A, Couillard M, Guillaume R et al. Overexpression of PKD1 causes polycystic kidney disease. Mol Cell Biol 2006; 26: 1538
(check this in PDF content)
17
Shibazaki S, Yu Z, Nishio S et al. Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkdl. Hum Mol Genet 2008; 17: 1505-1516
(check this in PDF content)
18
Hateboer N, van Dijk MA, Bogdanova N, Coto E et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. Lancet 1999;353: 103-107
(check this in PDF content)
19
Torra R, Badenas C, Perez-Oiler L et al. Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients. Am J Kidney Dis 2000; 36: 728-734
(check this in PDF content)
20
Barua M, Cil O, Paterson AD, Wang K et al. Family history of renal disease severity predicts the mutated gene in ADPKD. J Am Soc Nephrol 2009; 20(8):1833-1838
(check this in PDF content)
21
Harris PC, Bae K, Rossetti S et al. Cyst number but not the rate of cystic growth is associated with the mutated gene in ADPKD. J Am Soc Nephrol 2006;17: 3013-3019
(check this in PDF content)
22
Rossetti S, Chauveau D, Kubly V, Slezak J et al. Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet 2003; 361:2196-2201
(check this in PDF content)
23
Peral B, Ong A, San Millan JL et al. A stable, nonsense mutation associated with a case of infantile onset polycystic kidney disease 1. Hum Mol Genet 1996; 5: 539-542
(check this in PDF content)
24
Tazon-Vega B, Vilardell M, Perez-Oiler L et al. Study of candi-date genes affecting the progression of renal disease in auto-somal dominant polycystic kidney disease type 1. Nephrol Dial Transplant 2007; 22: 1567-1577
(check this in PDF content)
25
Belibi FA, Wallace DP, Yamaguchi T, Christensen M et al. The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2002; 13: 2723-2729
(check this in PDF content)
26
Wilson PD. Polycystic kidney disease: new understanding in the pathogenesis. Int J Biochem Cell Biol 2004; 36:1868-1873
(check this in PDF content)
27
Ostrom L, Tang M, Gruss P, Dressler G. Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease. Dev Biol 2000; 219(2): 250-258
(check this in PDF content)
28
Grantham JJ. Mechanisms of progression in autosomal dominant polycystic kidney disease. Kidney Int 1997; 63: 93-97
(check this in PDF content)
29
Nakamura T, Ushiyama C et al. Elevation of serum levels of metalloproteinase-1, tissue inhibitor of metalloproteinase- 1 and type IV collagen, and plasma levels of metalloproteinase- 9 in polycystic kidney disease. Am J Nephrol 2000; 20(1):32-36
(check this in PDF content)
30
Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 2009;76:149-168
(check this in PDF content)
31
Belibi FA, Edelstein CL. Novel targets for the treatment of autosomal dominant polycystic kidney disease. Expert Opin Investig Drugs 2010;19(3):315-328
(check this in PDF content)
32
Harris PC, Torres VE. Autosomal dominant polycystic disease in GeneClinics: Clinical Genetic Information Recourse [database online]. Copyright. University of Washington, Seattle. Available at http://www.geneclinics.org. Initial Posting: January 10, 2002. Last Revision: June 2, 2009
(check this in PDF content)
33
Nishiura JL, Neves RF, Eloi SR, Cintra SM et al. Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol 2009; (4), 838­ 844
(check this in PDF content)
34
Shamshirsaz A, Bekheirnia M et al. Autosomal- dominant polycystic kidney disease in infancy and childhood: progression and outcome. Kidney Int 2005; 68, 2218-2224
(check this in PDF content)
35
Андреева ЭФ. Клинико-генетическое исследование детей и подростков с поликистозом почек: Автореф. дис. канд. мед. наук. СПбГПМА. Спб., 2008;18
(check this in PDF content)
36
Ecder T, Schrier R. Cardiovascular abnormalities in autosomaldominant polycystic kidney disease. Nat Rev Nephrol 2009; 5: 221-222
(check this in PDF content)
37
Qian Q, Hunter LW, Du H, Ren Q, Han Y Sieck GC. Pkd2+/ - vascular smooth muscles develop exaggerated vasocontraction in response to phenylephrine stimulation. J Am Soc Nephrol 2007;18(2):485-493
(check this in PDF content)
38
Torres VE, Harris PC, Pirson Y Autosomal dominant polycystic kidney disease. Lancet 2007;369:1287-1301
(check this in PDF content)
39
Bae KT, Zhu F, Chapman AB, Torres VE et al. CRISP Consortium; Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the consortium for radiologic imaging studies of polycystic kidney disease cohort. Clin J Am Soc Nephrol 2006;1: 64-69
(check this in PDF content)
40
Kumar S, Adeva M, King BF, Kamath PS et al. Duodenal diverticulosis in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2006; 21: 3576-3588
(check this in PDF content)
41
Torra R, Sarquella J, Calabia J, Marta J et al. Prevalence of cysts in seminal tract and abnormal semen parameters in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2008;3(3):790-793
(check this in PDF content)
42
Leung GK, Fan YW. Chronic subdural haematoma and arachnoid cyst in autosomal dominant polycystic kidney disease (ADPKD). J Clin Neurosci 2005;12(7):817-819
(check this in PDF content)
43
Савенкова НД. Нефротический синдром при наслед­ ственных заболеваниях. В: Савенкова НД, Папаян АВ, ред. Нефротический синдром в практике педиатра. Эскулап, СПб., 1999; 149-150
(check this in PDF content)
44
Осипов ИБ, Колесникова ИФ. Поликистоз почек у детей (классификация, этиопатогенез, клиника, диагнос­ тика, лечебная тактика). Методические рекомендации. ГПМА, СПб.,2000; 22 с
(check this in PDF content)
45
Pirson X Chauveau D, Torres V. Management of cerebral aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2002;13: 269-276
(check this in PDF content)
46
Lumiaho A, Itoheimo R, Miettinen R, Niemitukia L et al. Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1. Am J Kidney Dis 2001;38(6):1208-1216
(check this in PDF content)
47
Godela M, Fick-Broshnan, Zung V et al. Progression of autosomal-dominant polycystic kidney diseasein children. Kidney Int 2001; 59: 1654-1662
(check this in PDF content)
48
Pei X Obaji J, Dupuis A, Paterson A. Unified Criteria for Ultrasonographic Diagnosis of ADPKD. J Am Soc Nephrol 2009; 20: 205-212
(check this in PDF content)
49
Wong H, Vivian L, Weiler G, Filler G. Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease. Am J Kidney Dis 2004;43(4):624-628
(check this in PDF content)
50
Ravine D, Gibson RN, Walker RG et al. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994; 343: 824-827
(check this in PDF content)
51
Rossetti S, Consugar MB, Chapman AB, Torres VE et al. CRISP Consortium; Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2007; 18: 2143-2160
(check this in PDF content)
52
Consugar MB, Wong WC, Lundquist PA et al. CRISP Consortium; Characterization of large rearrangements associated in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome. Kidney Int 2008; 74: 1468-1479
(check this in PDF content)
53
Badani KK, Hemal AK, Menon M. Autosomal dominant polycystic kidney disease and pain - a review of the disease from aetiology, evaluation, past surgical treatment options to current practice. J Postgrad Med 2004;50(3):222-226
(check this in PDF content)
54
Ruggenenti P, Remuzzi A, Ondei P et al. Safety and efficacy of long-acting somatostatin treatment in autosomal­ dominant polycystic kidney disease. Kidney Int 2005;68(1):206- 216
(check this in PDF content)
55
Keimpema L, Nevens F, Vanslembrouck R, van Oijen MG et al. Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2009;137(5):1661-1668
(check this in PDF content)
56
Torres VE. Role of vasopressin antagonists. Clin J Am Soc Nephrol 2008;3(4):1212-1218
(check this in PDF content)
57
Perico N, Antiga L, Caroli A, Ruggenenti P et al. Sirolimus therapy to halt the progression of ADPKD. J Am Soc Nephrol 2010; 21(6):1031-1040
(check this in PDF content)
58
Fassett RG, Coombes JS, Packham D, Fairley KF et al. Effect of pravastatin on kidney function and urinary protein excretion in autosomal dominant polycystic kidney disease. Scand J Urol Nephrol 2010; 44(1):56-61 Поступила в редакцию 04.08.2010 г.
(check this in PDF content)